At Hatteras Venture Partners, we believe that breakthrough science and entrepreneurial innovation have the power to create valuable new ways of treating and diagnosing disease, providing value for our investors and transforming human health.

The Hatteras team brings operational experience, a renowned strategic partner network, and a successful investment track record. We are passionate about utilizing our backgrounds to engage entrepreneurs and enhance the value of their companies.
Hatteras’ mission is to create transformative healthcare companies in the research-driven, undercapitalized regions of the Southeast and Mid-Atlantic. Over half of our portfolio companies were created with our initial investment.


Latest News

Clinipace Worldwide Expands into Asia with Acquisition of Choice Pharma

March 12, 2014

Choice Pharma provides Clinipace a significant Pan-Asia footprint MORRISVILLE, N.C. (Business Wire) March 11, 2014 – Clinipace Worldwide, a global digital contract research organization (dCRO), announced today the closing of its merger with Choice…

More News